RADNOR, Pa., June 22, 2020 /PRNewswire/ --
UNITED STATES DISTRICT COURT
DISTRICT OF ARIZONA
Richard Di Donato, Individually and On
SUMMARY NOTICE OF (I) PROPOSED SETTLEMENT WITH DEFENDANT
DARRYL S. BAKER; (II) SETTLEMENT FAIRNESS HEARING; AND
(III) MOTION FOR LITIGATION EXPENSES
All persons and entities who purchased or otherwise acquired Insys Therapeutics, Inc. ("Insys") common stock during the period from March 3, 2015, through January 25, 2016, and were damaged thereby ("Class"). Certain persons and entities are excluded from the Class as set forth in detail in the Stipulation and Agreement of Settlement between Lead Plaintiff and Defendant Darryl S. Baker dated May 22, 2020 ("Stipulation"), and the Settlement Notice described below.
PLEASE READ THIS NOTICE CAREFULLY;
YOUR RIGHTS WILL BE AFFECTED BY A
CLASS ACTION LAWSUIT PENDING IN THIS COURT.
YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of Arizona ("Court"), that the Court-appointed Lead Plaintiff and Class Representative Clark Miller ("Class Representative"), on behalf of himself and the Court-certified Class in the above-captioned securities class action ("Action"), has reached a proposed settlement of the Action with defendant Darryl S. Baker (the "Settling Defendant"), for $2,000,000 in cash that, if approved, will resolve all claims in the Action against the Settling Defendant only. Please Note: This settlement does not resolve any of the claims asserted against the other defendants in the Action and those claims are still being litigated.
A hearing will be held on September 23, 2020, at 1:30 p.m., before the Honorable Neil V. Wake at the Sandra Day O'Connor United States Courthouse, 401 W. Washington St., Phoenix, AZ 85003, Courtroom 401, to determine whether: (i) the proposed Settlement of the Action with the Settling Defendant should be approved as fair, reasonable, and adequate; (ii) the Action should be dismissed with prejudice against the Settling Defendant, and the releases specified and described in the Stipulation (and in the Settlement Notice described below) should be entered; (iii) the proposed Plan of Allocation should be approved as fair and reasonable; and (iv) Class Counsel's motion for litigation expenses should be approved.
If you are a member of the Class, your rights will be affected by the pending Action and the Settlement of the Action with the Settling Defendant, and you may be entitled to share in the Settlement Fund. This notice provides only a summary of the information contained in the detailed Notice of (I) Proposed Settlement with Defendant Darryl S. Baker; (II) Settlement Fairness Hearing; and (III) Motion for Litigation Expenses ("Settlement Notice"). You may obtain a copy of the Settlement Notice, along with the Claim Form, on the website for the Action, www.InsysRXSecuritiesLitigation.com. You may also obtain a copy of the Settlement Notice and the Claim Form by writing to the Claims Administrator at Insys Therapeutics, Inc. Securities Litigation, c/o A.B. Data, Ltd., P.O. Box 170999, Milwaukee, WI 53217; by calling toll free 1-866-905-8102; or by sending an email to info@InsysRXSecuritiesLitigation.com.
If you are a member of the Class, in order to be eligible to receive a payment under the proposed Settlement with the Settling Defendant, you must submit a Claim Form postmarked (if mailed), or online, no later than September 12, 2020, in accordance with the instructions set forth in the Claim Form. If you are a Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement of the Action with the Settling Defendant, but you will nevertheless be bound by any releases, judgments, or orders entered by the Court in the Action.
Any objections to the proposed Settlement of the Action with the Settling Defendant, the proposed Plan of Allocation, and/or Class Counsel's motion for litigation expenses, must be filed with the Court and delivered to Class Counsel and Settling Defendant's Counsel such that they are received no later than September 2, 2020, in accordance with the instructions set forth in the Settlement Notice. As this Class was previously certified and, in connection therewith, Class Members had the opportunity to exclude themselves from the Class, the Court has exercised its discretion not to allow a second opportunity for exclusion in connection with the settlement proceedings.
PLEASE DO NOT CONTACT THE COURT, THE CLERK'S OFFICE, THE SETTLING DEFENDANT, OR SETTLING DEFENDANT'S COUNSEL REGARDING THIS NOTICE. All questions about this notice, the Settlement of the Action with the Settling Defendant, or your eligibility to participate in the Settlement with the Settling Defendant should be directed to the Claims Administrator or Class Counsel.
Requests for the Settlement Notice and Claim Form should be made to the Claims Administrator:
Insys Therapeutics, Inc. Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 170999
Milwaukee, WI 53217
All other inquiries should be made to Class Counsel:
KESSLER TOPAZ MELTZER
& CHECK, LLP
Johnston de F. Whitman, Jr., Esq.
280 King of Prussia Road
Radnor, PA 19087
Telephone: (610) 667-7706
Facsimile: (610) 667-7056
Jennifer L. Joost, Esq.
One Sansome Street, Suite 1850
San Francisco, CA 94104
Telephone: (415) 400-3000
Facsimile: (415) 400-3001
DATED: June 22, 2020
BY ORDER OF THE COURT
United States District Court
District of Arizona
SOURCE Kessler Topaz Meltzer & Check, LLP